Tiedemann Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$461K Buy
13,090
+375
+3% +$12.6K 0.09% 46
2016
Q1
$377K Buy
12,715
+1,000
+9% +$30.1K 0.06% 55
2015
Q4
$378K Sell
11,715
-2,175
-16% -$72.1K 0.05% 58
2015
Q3
$436K Buy
13,890
+1,875
+16% +$63.4K 0.04% 42
2015
Q2
$403K Buy
12,015
+300
+3% +$10.3K 0.03% 55
2015
Q1
$408K Sell
11,715
-131
-1% -$4.39K 0.04% 45
2014
Q4
$369K Sell
11,846
-3,000
-20% -$90.7K 0.03% 54
2014
Q3
$438K Hold
14,846
– – 0.04% 65
2014
Q2
$440K Hold
14,846
– – 0.04% 65
2014
Q1
$476K Buy
14,846
+4,027
+37% +$127K 0.05% 67
2013
Q4
$331K Sell
10,819
-5,975
-36% -$183K 0.05% 67
2013
Q3
$482K Sell
16,794
-25,000
-60% -$717K 0.08% 48
2013
Q2
$1.17M Hold
41,794
– – 0.2% 39

Other funds holding PFE

Tiedemann Trust's PFE Position: Q2 2016 in Review

Tiedemann Trust increased its Pfizer (PFE) stake by 2.9% in Q2 2016, buying an estimated $12.6K and bringing the position to 13,090 shares worth $461K. The position accounts for 0.09% of the portfolio, ranked #46.

Tiedemann Trust first reported a position in PFE in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.17M in Q2 2013. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Tiedemann Trust held 13,090 shares of Pfizer worth $461K as of Q2 2016.
  • Tiedemann Trust bought 375 Pfizer shares in Q2 2016, an estimated $12.6K.
  • Pfizer made up 0.09% of Tiedemann Trust's portfolio in Q2 2016, its #46 holding.
  • Tiedemann Trust first reported a position in Pfizer in Q2 2013 and has held it in 13 quarters since.
  • Tiedemann Trust's Pfizer position peaked at $1.17M in Q2 2013.
  • 1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Tiedemann Trust's 13F filing for Q2 2016, filed 12 Aug 2016.